For the more than 18 million American cancer survivors — a designation that starts at diagnosis and lasts for life — the end of treatment marks the start of a different phase: follow-up appointments, ongoing monitoring, managing side effects and the challenge of learning to live with uncertainty.1
The good news is that there are more people surviving cancer than ever before. Improvements in cancer screening, targeted therapies and immunotherapy are allowing people to live longer and better following a cancer diagnosis. The 5-year survival rate for all cancers has now reached 70% — up from 50% in the mid-1970s.2
For employers and payers, that means members are spending more years on health plans and generating complex costs that go beyond the initial treatment episode.
This is why instead of being seen as an acute event that concludes with treatment, cancer is increasingly being seen as a chronic condition — one that calls for the same wraparound, long-term care used for diseases like diabetes or heart disease to help keep survivors healthy, comfortable and ready for whatever lies ahead.